Warning From Doctors: Antidepressants Could Permanently Impact Sexual Function

Warning From Doctors: Antidepressants Could Permanently Impact Sexual Function

Antidepressant use among young people carries serious risks, notably permanent sexual dysfunction such as total genital numbness, zero libido, and unresponsiveness to sexual stimuli. Selective serotonin reuptake inhibitors (SSRIs), a common type of antidepressant, are particularly implicated in causing post-SSRI sexual dysfunction (PSSD). This condition can also result from other medications affecting serotonin in the brain, including serotonin-norepinephrine reuptake inhibitors (SNRIs) and older tricyclic antidepressants.

Individuals with PSSD often face misdiagnosis, with their diminished libido and other sexual issues wrongly attributed to a relapse of depression or anxiety. However, PSSD can affect even those prescribed antidepressants for physical ailments.

The adverse sexual effects of antidepressants are well-documented, with recent studies suggesting these problems may persist after treatment cessation, potentially leading to irreversible sexual dysfunction. In response, the European Medicines Agency (EMA) mandated warnings on SSRIs and SNRIs in 2019, acknowledging the risks of PSSD. Similar regulatory pressures are emerging globally.

PSSD symptoms include genital numbness, difficulty achieving orgasm, joyless orgasms, erectile dysfunction, vaginal dryness, and reduced sex drive. Emotional numbing, where individuals experience a dulled ability to feel both positive and negative emotions, is also common.

Medical professionals are actively seeking solutions. Joanna Moncrieff, a professor at University College London specializing in psychiatry, emphasizes the profound impact of serotonin-altering drugs on sexuality. She highlights growing concerns over rising antidepressant prescriptions for teenagers, noting that these medications can alter brain chemistry in ways that are poorly understood, particularly worrisome during puberty.

There is a consensus among experts that patients already using antidepressants should be informed about the potential for persistent sexual dysfunction and supported in exploring alternatives to medication where appropriate.